Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jun 15, 2021; 13(6): 574-588
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.574
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.574
Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatment
Keun-Yeong Jeong, Minhee Park, Research and Development, Metimedi Pharmaceuticals, Incheon 22006, South Korea
Author contributions: Jeong KY collected references and designed the contents; Jeong KY and Park MH wrote the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: We have no conflict of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Keun-Yeong Jeong, PhD, Executive Vice President, Research Assistant Professor, Research and Development, Metimedi Pharmaceuticals, 263 Central-ro, Incheon 22006, South Korea. alvirus@naver.com
Received: February 25, 2021
Peer-review started: February 25, 2021
First decision: April 19, 2021
Revised: April 22, 2021
Accepted: May 8, 2021
Article in press: May 8, 2021
Published online: June 15, 2021
Peer-review started: February 25, 2021
First decision: April 19, 2021
Revised: April 22, 2021
Accepted: May 8, 2021
Article in press: May 8, 2021
Published online: June 15, 2021
Core Tip
Core Tip: The main focus is on highlighting the pivotal role of poly adenosine diphosphate-ribose polymerase-1 (PARP-1) and poly-adenosine diphosphate ribosylation (PARylation) in regulating deoxyribonucleic acid damage response, redox homeostasis, chromosomal instability, and transcriptional activity under the common denominator of overcoming the genomic instability in colorectal cancer (CRC). The importance of targeting PARP-1 and PARylation in the treatment of CRC will be emphasized because the level of understanding of pathological changes leading to malignant transformation of CRC by PARP-1 and PARylation may increase.